{"id":46252,"date":"2022-07-15T20:01:51","date_gmt":"2022-07-15T18:01:51","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/cresco-labs-announces-voting-results-of-its-annual-and-special-meeting-of-shareholders\/"},"modified":"2022-07-15T20:01:51","modified_gmt":"2022-07-15T18:01:51","slug":"cresco-labs-announces-voting-results-of-its-annual-and-special-meeting-of-shareholders","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/cresco-labs-announces-voting-results-of-its-annual-and-special-meeting-of-shareholders\/","title":{"rendered":"Cresco Labs Announces Voting Results of Its Annual and Special Meeting of Shareholders"},"content":{"rendered":"<div>\n<p>CHICAGO&#8211;(BUSINESS WIRE)&#8211;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.crescolabs.com%2F&amp;esheet=52782486&amp;newsitemid=20220715005423&amp;lan=en-US&amp;anchor=Cresco+Labs&amp;index=1&amp;md5=687c6d0fc9d77f9b9cbce4a6801b365c\" rel=\"nofollow noopener\" shape=\"rect\"><b>Cresco Labs<\/b><\/a> (CSE:CL) (OTCQX:CRLBF) (\u201c<b>Cresco Labs<\/b>\u201d or the \u201c<b>Company<\/b>\u201d), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, conducted its annual and special meeting of shareholders (the \u201c<b>Meeting<\/b>\u201d) today, July 15, 2022 at 10:00 a.m. (Central Time).\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220715005423\/en\/1055904\/5\/PR_BW_LOGO.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220715005423\/en\/1055904\/21\/PR_BW_LOGO.jpg\"><\/a><\/p>\n<p>\nAt the Meeting, the number of directors on the board of directors of the Company for the ensuing year was fixed at eleven (11) by the shareholders and the following nominees for election as directors of the Company were elected by a majority of votes cast by the shareholders virtually present or represented by proxy at the Meeting:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nCharles Bachtell\n<\/li>\n<li>\nRobert M. Sampson\n<\/li>\n<li>\nJohn R. Walter\n<\/li>\n<li>\nGerald F. Corcoran\n<\/li>\n<li>\nThomas J. Manning\n<\/li>\n<li>\nRandy D. Podolsky\n<\/li>\n<li>\nMarc Lustig\n<\/li>\n<li>\nMichele Roberts\n<\/li>\n<li>\nCarol Vallone\n<\/li>\n<li>\nTarik Brooks\n<\/li>\n<li>\nSidney Dillard\n<\/li>\n<\/ul>\n<p>\nFurther, Marcum LLP was reappointed as the Company\u2019s auditor for the ensuing year.\n<\/p>\n<p>\nThe final matter voted on at the Meeting relates to the Company\u2019s Super Voting Shares. On June 3, 2022, the Company amended and restated the investment agreement (the \u201c<b>Investment Agreement<\/b>\u201d), originally dated as of November 30, 2018, among the holders of the Super Voting Shares and the Company. As amended and restated, the Investment Agreement provides that the Company will repurchase (the \u201c<b>Share Repurchase<\/b>\u201d) all of the Super Voting Shares for an aggregate amount of $800,001, equivalent to the aggregate consideration paid by the holders for such Super Voting Shares, not later than the first business day after the first annual meeting of shareholders of the Company following a future listing of the Company\u2019s Subordinate Voting Shares on a United States national securities exchange (a \u201c<b>U.S. Listing Event<\/b>\u201d), such as NASDAQ or The New York Stock Exchange.\n<\/p>\n<p>\nAt the Meeting, the shareholders approved the special resolution (the \u201c<b>Special Resolution<\/b>\u201d) to amend the articles of the Company such that following any future listing U.S. Listing Event: (i) the Company may not issue any new Super Voting Shares, (ii) any Super Voting Shares repurchased by the Company must be cancelled and may not be reissued, and (iii) at the time there are no Super Voting Shares outstanding, the Company may take such appropriate action (without the need for future shareholder action or approval) as may be necessary to remove the Super Voting Shares from the Company\u2019s authorized share structure.\n<\/p>\n<p>\nAfter the amendment of the Company\u2019s articles contemplated by the Special Resolution and the completion of the Share Repurchase following a U.S. Listing Event, no Super Voting Shares will remain outstanding and the Company will be unable to issue new Super Voting Shares.\n<\/p>\n<p>\n<b>About Cresco Labs Inc.<\/b>\n<\/p>\n<p>\nCresco Labs is one of the largest vertically integrated multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods (\u201c<b>CPG<\/b>\u201d) approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco, High Supply, Mindy&#8217;s Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, Cresco Labs\u2019 national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry\u2019s largest Social Equity and Educational Development initiative, SEED, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.crescolabs.com&amp;esheet=52782486&amp;newsitemid=20220715005423&amp;lan=en-US&amp;anchor=www.crescolabs.com&amp;index=2&amp;md5=07a38be71fb1e40ee70f767585e1edbf\" rel=\"nofollow noopener\" shape=\"rect\">www.crescolabs.com<\/a>.\n<\/p>\n<p>\nFacebook: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2FCrescoLabsOfficial&amp;esheet=52782486&amp;newsitemid=20220715005423&amp;lan=en-US&amp;anchor=Cresco+Labs&amp;index=3&amp;md5=1c376f501c3051ead23b603443a2c3c8\" rel=\"nofollow noopener\" shape=\"rect\">Cresco Labs<\/a>\n<\/p>\n<p>\nInstagram: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.instagram.com%2Fcrescolabs%2F%3Fhl%3Den&amp;esheet=52782486&amp;newsitemid=20220715005423&amp;lan=en-US&amp;anchor=Cresco+Labs&amp;index=4&amp;md5=fdcbe2512fd39dcd21dcf1e6098e2e53\" rel=\"nofollow noopener\" shape=\"rect\">Cresco Labs<\/a>\n<\/p>\n<p>\nTwitter: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2Fcrescolabs%3Flang%3Den&amp;esheet=52782486&amp;newsitemid=20220715005423&amp;lan=en-US&amp;anchor=Cresco+Labs&amp;index=5&amp;md5=c8e0e222e073a8c035433749f3a0d5cc\" rel=\"nofollow noopener\" shape=\"rect\">Cresco Labs<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<i>Media:<\/i><br \/>Jason Erkes, Cresco Labs<br \/>\n<br \/>Chief Communications Officer<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#x69;l&#116;&#x6f;:&#112;&#x72;&#x65;&#115;&#x73;&#x40;c&#114;&#x65;s&#99;&#x6f;&#x6c;&#97;&#x62;&#x73;&#46;&#99;&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#114;&#x65;&#115;s&#x40;&#99;r&#x65;&#115;&#x63;&#x6f;l&#x61;&#98;s&#x2e;&#99;&#x6f;&#x6d;<\/a>\n<\/p>\n<p>\n<i>Investors:<\/i><br \/>Megan Kulick, Cresco Labs<br \/>\n<br \/>Senior Vice President, Investor Relations<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#x69;l&#116;&#x6f;&#x3a;i&#110;&#x76;e&#115;&#x74;&#x6f;r&#115;&#x40;c&#114;&#x65;&#x73;c&#111;&#x6c;&#x61;&#98;&#x73;&#x2e;c&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#105;&#x6e;v&#101;&#x73;t&#111;&#x72;s&#64;&#x63;r&#101;&#x73;&#99;&#x6f;&#x6c;&#97;&#x62;&#x73;&#46;&#x63;o&#109;<\/a>\n<\/p>\n<p>\n<i>For general Cresco Labs inquiries:<\/i><br \/>312-929-0993<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;a&#x69;&#108;t&#x6f;&#58;&#x69;&#110;f&#x6f;&#64;&#x63;&#114;e&#x73;&#99;&#x6f;&#x6c;a&#x62;&#115;&#46;&#x63;&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x69;n&#x66;o&#x40;&#99;&#x72;&#101;s&#x63;o&#x6c;&#97;&#x62;&#115;&#x2e;&#99;o&#x6d;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>CHICAGO&#8211;(BUSINESS WIRE)&#8211;Cresco Labs (CSE:CL) (OTCQX:CRLBF) (\u201cCresco Labs\u201d or the \u201cCompany\u201d), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, conducted its annual and special meeting of shareholders (the \u201cMeeting\u201d) today, July 15, 2022 at 10:00 a.m. (Central Time). At the Meeting, the number of directors on the board of &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/cresco-labs-announces-voting-results-of-its-annual-and-special-meeting-of-shareholders\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46252","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cresco Labs Announces Voting Results of Its Annual and Special Meeting of Shareholders - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/cresco-labs-announces-voting-results-of-its-annual-and-special-meeting-of-shareholders\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cresco Labs Announces Voting Results of Its Annual and Special Meeting of Shareholders - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CHICAGO&#8211;(BUSINESS WIRE)&#8211;Cresco Labs (CSE:CL) (OTCQX:CRLBF) (\u201cCresco Labs\u201d or the \u201cCompany\u201d), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, conducted its annual and special meeting of shareholders (the \u201cMeeting\u201d) today, July 15, 2022 at 10:00 a.m. (Central Time). At the Meeting, the number of directors on the board of ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/cresco-labs-announces-voting-results-of-its-annual-and-special-meeting-of-shareholders\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-15T18:01:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220715005423\/en\/1055904\/21\/PR_BW_LOGO.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cresco-labs-announces-voting-results-of-its-annual-and-special-meeting-of-shareholders\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cresco-labs-announces-voting-results-of-its-annual-and-special-meeting-of-shareholders\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Cresco Labs Announces Voting Results of Its Annual and Special Meeting of Shareholders\",\"datePublished\":\"2022-07-15T18:01:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cresco-labs-announces-voting-results-of-its-annual-and-special-meeting-of-shareholders\\\/\"},\"wordCount\":665,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cresco-labs-announces-voting-results-of-its-annual-and-special-meeting-of-shareholders\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220715005423\\\/en\\\/1055904\\\/21\\\/PR_BW_LOGO.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cresco-labs-announces-voting-results-of-its-annual-and-special-meeting-of-shareholders\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cresco-labs-announces-voting-results-of-its-annual-and-special-meeting-of-shareholders\\\/\",\"name\":\"Cresco Labs Announces Voting Results of Its Annual and Special Meeting of Shareholders - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cresco-labs-announces-voting-results-of-its-annual-and-special-meeting-of-shareholders\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cresco-labs-announces-voting-results-of-its-annual-and-special-meeting-of-shareholders\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220715005423\\\/en\\\/1055904\\\/21\\\/PR_BW_LOGO.jpg\",\"datePublished\":\"2022-07-15T18:01:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cresco-labs-announces-voting-results-of-its-annual-and-special-meeting-of-shareholders\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cresco-labs-announces-voting-results-of-its-annual-and-special-meeting-of-shareholders\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cresco-labs-announces-voting-results-of-its-annual-and-special-meeting-of-shareholders\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220715005423\\\/en\\\/1055904\\\/21\\\/PR_BW_LOGO.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220715005423\\\/en\\\/1055904\\\/21\\\/PR_BW_LOGO.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/cresco-labs-announces-voting-results-of-its-annual-and-special-meeting-of-shareholders\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cresco Labs Announces Voting Results of Its Annual and Special Meeting of Shareholders\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cresco Labs Announces Voting Results of Its Annual and Special Meeting of Shareholders - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/cresco-labs-announces-voting-results-of-its-annual-and-special-meeting-of-shareholders\/","og_locale":"en_US","og_type":"article","og_title":"Cresco Labs Announces Voting Results of Its Annual and Special Meeting of Shareholders - Pharma Trend","og_description":"CHICAGO&#8211;(BUSINESS WIRE)&#8211;Cresco Labs (CSE:CL) (OTCQX:CRLBF) (\u201cCresco Labs\u201d or the \u201cCompany\u201d), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, conducted its annual and special meeting of shareholders (the \u201cMeeting\u201d) today, July 15, 2022 at 10:00 a.m. (Central Time). At the Meeting, the number of directors on the board of ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/cresco-labs-announces-voting-results-of-its-annual-and-special-meeting-of-shareholders\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-15T18:01:51+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220715005423\/en\/1055904\/21\/PR_BW_LOGO.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/cresco-labs-announces-voting-results-of-its-annual-and-special-meeting-of-shareholders\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/cresco-labs-announces-voting-results-of-its-annual-and-special-meeting-of-shareholders\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Cresco Labs Announces Voting Results of Its Annual and Special Meeting of Shareholders","datePublished":"2022-07-15T18:01:51+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cresco-labs-announces-voting-results-of-its-annual-and-special-meeting-of-shareholders\/"},"wordCount":665,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cresco-labs-announces-voting-results-of-its-annual-and-special-meeting-of-shareholders\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220715005423\/en\/1055904\/21\/PR_BW_LOGO.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/cresco-labs-announces-voting-results-of-its-annual-and-special-meeting-of-shareholders\/","url":"https:\/\/pharma-trend.com\/en\/cresco-labs-announces-voting-results-of-its-annual-and-special-meeting-of-shareholders\/","name":"Cresco Labs Announces Voting Results of Its Annual and Special Meeting of Shareholders - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/cresco-labs-announces-voting-results-of-its-annual-and-special-meeting-of-shareholders\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/cresco-labs-announces-voting-results-of-its-annual-and-special-meeting-of-shareholders\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220715005423\/en\/1055904\/21\/PR_BW_LOGO.jpg","datePublished":"2022-07-15T18:01:51+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/cresco-labs-announces-voting-results-of-its-annual-and-special-meeting-of-shareholders\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/cresco-labs-announces-voting-results-of-its-annual-and-special-meeting-of-shareholders\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/cresco-labs-announces-voting-results-of-its-annual-and-special-meeting-of-shareholders\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220715005423\/en\/1055904\/21\/PR_BW_LOGO.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220715005423\/en\/1055904\/21\/PR_BW_LOGO.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/cresco-labs-announces-voting-results-of-its-annual-and-special-meeting-of-shareholders\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Cresco Labs Announces Voting Results of Its Annual and Special Meeting of Shareholders"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46252","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46252"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46252\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46252"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46252"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46252"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}